<DOC>
	<DOCNO>NCT00976794</DOCNO>
	<brief_summary>The purpose study determine efficacy combination lithium carbamazepine compare lithium valproate treat young bipolar patient .</brief_summary>
	<brief_title>Efficacy Combined Treatment Young Bipolar I Disorder</brief_title>
	<detailed_description>After diagnostic assessment , patient allocate one follow group treatment : Group I : lithium + valproic acid Group II : lithium + carbamazepine Patients follow 8 week phase I ( acute treatment ) , 6 month phase II ( continuation treatment ) 12 month phase III ( maintenance treatment ) . Scales raters blind treatment . During phase II III continue patient achieve response , measure accord initial symptom score phase I .</detailed_description>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Clinical diagnosis Bipolar Disorder , type I , current episode ( manic/hypomanic , mixed depression ) The patient ( ) legal representative understand nature study sign Informed Consent . Schizophrenia schizoaffective disorder Mental retardation Unstable clinical disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>BD I</keyword>
</DOC>